Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

2025-03-13 11:04:29 ET

Seres Therapeutics, Inc. (MCRB)

Q4 2024 Earnings Conference Call

March 13, 2025, 8:30 AM ET

Company Participants

Carlo Tanzi - Kendall Investor Relations

Eric Shaff - President and Chief Executive Officer

Lisa von Moltke - Executive Vice President and Chief Medical Officer

Matthew Henn - Executive Vice President and Chief Scientific Officer

Terri Young - Executive Vice President, Chief Commercial and Strategy Officer

Marella Thorell - Executive Vice President and Chief Financial Officer

Chris McChalicher - Senior Vice President, Manufacturing, Quality and Process Development

Conference Call Participants

Joseph Thome - TD Cowen

Caroline Pocher - JPMorgan

Edward Tenthoff - Piper Sandler

John Newman - Canaccord Genuity

Presentation

Operator

Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q4 2024 Seres Therapeutics Incorporated Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [Operator Instructions] Thank you.

I would now like to turn the call over to Carlo Tanzi of Investor Relations. Please go ahead.

Carlo Tanzi

Thank you and good morning. Our press release with the company's fourth quarter and full year 2024 financial results and business updates became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors & News section of the company's website. The company has also posted an updated corporate presentation to the website....

Read the full article on Seeking Alpha

For further details see: